Eunus S. Ali
Also known as: Eunus
University of Kentucky College of Medicine, Northwestern University, Flinders University Medicine Program, Stockholm University
Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · Biochemical and Molecular Research · Cancer, Hypoxia, and Metabolism · Glioma Diagnosis and Treatment
About
Improving obesity- and cancer-related metabolic dysfunctions by investigating and controlling body’s’ signaling pathways and metabolism has been the focus of Eunus Ali Lab’s research. Using biochemistry and cell biology, he works at the molecular level to identify how to efficiently restore aberrant cellular signaling in cancer, diabetes, aging and neurological diseases. He has published some significant works in this area in several well-ranked journals including Molecular Cell, Science Advances, Nature Communications, Brain, BBA - Molecular Cell Research, Biochemical Journal and AJP - Cell Physiology. Prior to Postdoc with Dr. Issam Ben-Sahra at Northwestern University, his PhD was completed under the supervision of Dr. Greg Barritt at Flinders University, and MS at Stockholm's Arrhenius Laboratory with Dr. Göran Widmalm.
His research team is currently pursuing several major lines of metabolic research:
Research Focus #1: Obesity and Diabetes: One of the major lines of research in the lab is to elucidate the molecular and cellular Ca2+-dependent mechanisms underlying obesity, type-2 diabetes and obesity-associated cancers, with the goal of translating the findings into next-generation therapeutics.
Research Focus #2: Cellular Metabolism: Employing high resolution mass spectrometry, biochemical approaches and genome editing CRISPR, Eunus identified two important mechanisms in cell metabolism - in response to growth or oncogenic signals, how cells increase nucleotide metabolism to boost their cell proliferation. Both studies have separately been published in Molecular Cell. Further, two additional projects related to cellular nucleotide, and lipid metabolism are being conducted in the lab.
As an Assistant Professor, Eunus currently directs 'Laboratory for Cellular and Cancer Metabolism' in the Department of Toxicology and Cancer Biology, and the Markey Cancer Center. He is also a member of the Center for Cancer and Metabolism, and Barnstable Brown Diabetes and Obesity Center in the University of Kentucky College of Medicine. The overview of current research program can be found in the lab website:
https://eal-metabolab.com/
Employment
-
University of Kentucky College of Medicine Assistant Professor2024 - Present
Education
-
Northwestern University Postdoc? - 2024
-
Flinders University Medicine Program Ph.D.? - 2017
-
Stockholm University M.S.? - 2011
Projects & Funding
Projects & funding information is unavailable.
Publications (31)
- PLK1-mediated phosphorylation of PHGDH reprograms serine metabolism in advanced prostate cancer Save
- Calcium Imaging in H4IIE Liver Cells and Primary Rodent Hepatocytes: A Cost-Effective Protocol for Use With Fura-2 AM Ca2+ Indicator Save
- PLK1-mediated phosphorylation of PHGDH reprograms serine metabolism in advanced prostate cancer Save
- Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor Save
- Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production Save
- Regulation of nucleotide metabolism in cancers and immune disorders. Save
- Purine nucleotide depletion prompts cell migration by stimulating the serine synthesis pathway Save
- Recent advances and limitations of mTOR inhibitors in the treatment of cancer. Save
- The mTORC1-SLC4A7 axis stimulates bicarbonate import to enhance de novo nucleotide synthesis Save
- TRPM2 Non-Selective Cation Channels in Liver Injury Mediated by Reactive Oxygen Species Save
- Targeting redox signaling and ROS metabolism in cancer treatment Save
- The phytochemical, biological, and medicinal attributes of phytoecdysteroids: An updated review Save
- Impaired Ca2+ signaling due to steatosis mediates hepatic insulin resistance in Alstrom Syndrome mice that is reversed by GLP-1 analog treatment. Save
- De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma Save
- mTORC1 stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis. Save
- Anticancer Perspectives on the Fungal-Derived Polyphenolic Hispolon Save
- Targeting Ca2+ Signaling in the Initiation, Promotion and Progression of Hepatocellular Carcinoma Save
- ERK2 Phosphorylates PFAS to Mediate Posttranslational Control of De Novo Purine Synthesis Save
- Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides Save
- Calcium Signaling As a Therapeutic Target for Liver Steatosis Save